Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine + inotropics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 100 µg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1000 µg/ml injektionsvæske, opløsning fyldt pen a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 500 µg/ml injektionsvæske, opløsning i fyldt pen a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 100 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine [resp] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1:1000 1 mg/ml opløsning til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 0,01 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,05 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,25 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1:10.000 100 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Adrenaline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
adrenalin øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 2 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid pellet a 1,9 mg til dental anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1,15 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine hydrochloride 0.5mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 0,85 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1,15 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 0,82 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 0.5 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine 1mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine 0.5mg/mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrin 1 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrin 500 µg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 2,0 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Adrenaline 5 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 1,0 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 0,108 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 0,6 mg pellets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1,7 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrinhydrochlorid 0,182 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrinhydrochlorid 0,364 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinhydrochlorid 1 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
articainhydrochlorid 40 mg + adrenalin 10 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 20 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine + lidocaine hydrochloride 20mcg/20mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalin 5 µg + lidocainhydrochlorid 15 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 5 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 1 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 4 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilocarpinhydrochlorid 6 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 2 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Epinephrine bitartrate (substance) |
Is a |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Adrenaline hydrochloride |
Is a |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine acetate (substance) |
Is a |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrinsyretartrat, kemisk stof |
Is a |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Accidental adrenalin poisoning |
Causative agent |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Intentional adrenalin poisoning |
Causative agent |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
forgiftning med adrenalin, uvist med hvilken hensigt |
Causative agent |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenalininjektion til hæmostase af gastrisk morfologisk forandring i |
Direct substance |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
3 |
Adrenalininjektion til hæmostase af duodenallæsion |
Direct substance |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
zinksulfat + adrenalin øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 0,5 %/1:200.000 injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing cocaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
lidocainhydrochlorid + adrenalin 2 %/1:80.000 cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
cocain 5 % + epinephrin 0,02 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
guanethidinmonosulfat 1 % + adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
guanethidinmonosulfat 0,5 % + adrenalin 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 4 % næsedråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Poisoning by epinephrine |
Causative agent |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Injection of adrenaline |
Direct substance |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
lidocainhydrochlorid 1,5 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:500.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 5 mg + adrenalinbitartrat 0,0091 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
epinephrinpræparat til respirationssystemet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine and fluorouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
etidocainhydrochlorid + adrenalin 1,5 %/1:200.000 injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocain 2 %/adrenalin 1 til 200.000 injektionsvæske, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
etidocainhydrochlorid + adrenalin 1,5 %/1:200.000 injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
lidocain 1 %/adrenalin 1 til 200.000 injektionsvæske, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
Product containing bupivacaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
guanethidinmonosulfat 0,25 % + adrenalin 0,05 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|
bupivacain + adrenalin 0,25 %/1:200.000 sterilt indpakket injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
|